|Bid||61.01 x 1100|
|Ask||61.79 x 1300|
|Day's Range||60.80 - 61.97|
|52 Week Range||57.04 - 85.97|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||60.70|
|Earnings Date||Feb 02, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||2.72 (4.48%)|
|Ex-Dividend Date||Dec 14, 2020|
|1y Target Est||73.72|
Diodes Incorporated (Nasdaq: DIOD) today announced management will present at the following virtual financial conferences.
Investors looking for dividend-paying stocks that offer juicy yields right now can find what they're looking for in the biopharmaceutical industry. All three of these big pharmaceutical companies have well-funded dividend programs that offer juicy yields above 4% right now. Since spinning off from Abbott in 2013, AbbVie has raised its dividend payout a whopping 225% with help from its top-selling rheumatoid arthritis treatment, Humira.
\\-- PrEP is part of the ongoing efforts by Gilead Canada to end the HIV epidemic--MISSISSAUGA, ON, Dec. 1, 2020 /CNW/ - Gilead Sciences Canada, Inc.